UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON D.C. 20549

SCHEDULE 14A
(Rule 14a-101)

INFORMATION REQUIRED IN PROXY STATEMENT
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934

Filed by the Registrant x

Filed by a Party other than the Registrant o

Check the appropriate box:

o Preliminary proxy statement
o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
o Definitive proxy statement
x Definitive Additional Materials
o Soliciting Material pursuant to § 240.14a-12

Advocat Inc.

(Name of Registrant as Specified In Its charter)

(Name of Person(s) Filing proxy statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

x No fee required.
o Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

(1)	Title of each class of securities to which transaction applies:
(2)	Aggregate number of securities to which transaction applies:
(3)	Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
(4)	Proposed maximum aggregate value of transaction:
(5)	Total fee paid:
o	Fee paid previously with preliminary materials.
o	Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
(1)	Amount Previously Paid:
(2)	Form, Schedule or Registration Statement No.:
(3)	Filing Party:
(4)	Date Filed:

     On May 19, 2009, Bristol Investment Fund Ltd. (“Bristol”) filed definitive additional proxy information that it sent to Advocat Inc. shareholders and used in a slide presentation to RiskMetrics Group. These proxy materials include several comparisons that we believe are skewed because of the different capital structures of the comparative companies and also focuses on only one year. As a result, in response, the Company is sending the following additional information to RiskMetrics Group.

     Bristol identified four companies in its proxy statement that Bristol believes are comparable to Advocat. These companies are The Ensign Group, Inc. (ENSG), Kindred Heathcare Inc. (KND), Skilled Healthcare Group, Inc. (SKH) and Sun Healthcare Group, Inc. (SUNH). Certain financial information and data used herein has been obtained from filings made with the Securities and Exchange Commission (the “SEC”) by these companies other than Advocat. Advocat is not responsible for any misinformation contained in any third party SEC filing or third party report.

     Advocat Inc. leases more of its skilled nursing portfolio than the other companies that Bristol included in its slide presentation. A more reflective analysis of pre-financing cash flow of a business is to look at EBITDAR (earnings before interest, taxes, depreciation, amortization and rent). Below is the ratio of EBITDAR to shares outstanding. As you can see, when you adjust the information to eliminate the difference in the capital structures of the companies, Advocat has performed favorably over the past three years.

Data Information

		2008		2007			2006
KND	Net Income		36,285,000		(46,870,000	)		78,711,000
	EBITDAR		553,287,000		531,405,000			540,195,000
	Dilutive shares		38,906,000		39,983,000			40,923,000
	Ratio		14.221		13.291			13.200
SKH	Net Income		37,209,000		9,795,000			17,337,000
	EBITDAR		130,335,000		113,226,000			96,849,000
	Dilutive shares		36,894,000		27,715,000			11,638,000
	Ratio		3.533		4.085			8.322
ENSG	Net Income		27,509,000		20,527,000			22,549,000
	EBITDAR		72,613,000		60,359,000			59,517,000
	Dilutive shares		20,715,000		17,470,000			16,823,000
	Ratio		3.505		3.455			3.538
SUNH	Net Income		109,287,000		57,510,000			27,118,000
	EBITDAR		234,371,000		192,470,000			96,654,000
	Dilutive shares		43,963,000		43,390,000			31,788,000
	Ratio		5.331		4.436			3.041
AVCA	Net Income		5,735,000		9,387,000			21,944,000
	EBITDAR		40,417,000		41,709,000			35,589,000
	Dilutive shares		5,887,000		6,127,000			6,507,000
	Ratio		6.865		6.807			5.469

     Advocat provides financial measures using accounting principles generally accepted in the United States (GAAP) and using adjustments to GAAP (non-GAAP). EBITDAR is not a measurement under GAAP. EBITDAR should be considered in addition to, but not as a substitute for, the information contained in our financial statements prepared in accordance with GAAP. EBITDAR is defined as net income before other income, interest income and expense, debt retirement costs, foreign currency transaction gains and losses, the provision or benefit for income taxes, depreciation and amortization expense, rent expense, and the net income or loss from discontinued operations. Management believes that EBITDAR is an important measurement of the Company’s performance because it eliminates the effect of differences in the financing of nursing homes by removing rent expense and interest expense from net income. Reconciliations for these non-GAAP financial measurements for Advocat to the most comparable GAAP measure as required by Regulation G are shown below.

Additional Information and Where To Find It
This information may be deemed to be solicitation material in respect of the matters to be considered at the 2009 annual meeting of shareholders. The Company has filed the definitive proxy statement with the Securities and Exchange Commission (“SEC”) on May 5, 2009. Investors and shareholders are urged to read the proxy statement, the white proxy card and any other relevant documents filed or that will be filed with the SEC because they contain important information. Investors and shareholders may obtain the proxy statement and other relevant documents free of charge at the SEC’s Web site, www.sec.gov; at Advocat’s website, www.irinfo.com/AVC; or from Advocat Inc., 1621 Galleria Boulevard, Brentwood, Tennessee 37027.

Participants in Solicitation
Advocat and its directors and certain executive officers may be deemed to be participants in the solicitation of proxies in respect of the matters to be considered at the 2009 annual meeting of shareholders. Information regarding the interests of Advocat’s directors and executive officers in the proxy contest is included in Advocat’s definitive proxy statement.

Reconciliation of Advocat’s EBITDAR to Net Income

Advocat Inc.
Reconciliation of EBITDAR to Net Income
Dollars in thousands	2008			2007			2006
Earnings before Interest, Taxes, Depreciation, Amortization and Rent (EBITDAR)	$	40,417		$	41,709		$	35,589
Other income		—			—			207
Interest income		454			1,016			679
Interest expense		(2,870	)		(3,549	)		(3,707	)
Debt retirement costs		—			(116	)		(194	)
Foreign currency transaction gain (loss)		(1,005	)		808			21
Net loss from discontinued operations		(35	)		(99	)		(451	)
Provision for income taxes		(2,958	)		(6,270	)		9,496
Depreciation and amortization		(5,306	)		(4,093	)		(3,614	)
Rent		(22,962	)		(20,019	)		(16,082	)
Net income	$	5,735		$	9,387		$	21,944